Adipotide 10 mg

Dragon Pharma Adipotide

Adipotide 10 mg represents a cutting-edge approach to targeted fat loss in the research peptide landscape. Unlike traditional fat burners that stimulate metabolism systemically, Adipotide (also known as FTPP - Fat Tissue Targeting Peptide) functions through a sophisticated mechanism that selectively targets and disrupts the blood supply to white adipose tissue. This innovative peptide was initially developed for research into obesity and metabolic disorders, demonstrating a unique ability to cause programmed cell death (apoptosis) specifically in fat cells by binding to two receptors found abundantly in their blood vessels.

For bodybuilders and fitness enthusiasts in the USA seeking to achieve extreme definition and shed stubborn fat deposits that resist diet and exercise, Dragon Pharma Adipotide 10 mg offers a research-focused tool. It is particularly noted for its potential to target visceral and subcutaneous fat, areas critical for achieving the coveted "shredded" physique. Manufactured by Dragon Pharma in certified European facilities, this 10 mg lyophilized powder vial ensures high purity, accuracy in dosing, and stability for research purposes. The product undergoes rigorous quality control, providing researchers with a reliable and potent compound for studying advanced fat-loss protocols.

Key Benefits:

• Targeted Fat Reduction: Selectively disrupts blood supply to white adipose tissue, promoting apoptosis in stubborn fat cells.
• Visceral Fat Focus: Research suggests particular efficacy against deep visceral fat, which is linked to metabolic health.
• Non-Stimulatory Action: Works via a vascular mechanism, not the central nervous system, avoiding stimulant-like side effects.
• Preserves Lean Mass: The targeted approach aims to spare muscle tissue during a caloric deficit, crucial for bodybuilders.
• Potent & Research-Grade: High 10 mg per vial concentration provides ample material for precise, controlled research studies.

Each 2 mL vial contains 10 mg of ultra-pure Adipotide peptide as a lyophilized powder, manufactured under strict GMP-like quality control standards in Dragon Pharma's certified facilities for research use.

Product Specifications

Usage Guidelines

Important Note: The following information is derived from preclinical research literature and is presented for educational purposes only. Dragon Pharma Adipotide 10 mg is sold as a research chemical strictly for laboratory use in vitro or in animal models under appropriate ethical guidelines. It is not for human consumption.

In experimental models, Adipotide is reconstituted with bacteriostatic water. The dosage and administration frequency in these models vary significantly based on the study design and subject. Researchers should design protocols based on current scientific literature, emphasizing that the peptide's mechanism involves targeted blood vessel disruption, warranting careful consideration of cycle length to avoid unintended effects.

• Experimental Model Protocol 1 (Short-term): Often involves daily administration for a limited period (e.g., 1-2 weeks) followed by a significant observation period to assess targeted fat cell apoptosis and systemic response.
• Experimental Model Protocol 2 (Intermittent): Some research explores intermittent dosing (e.g., several days on, several days off) to manage the pharmacodynamic response and assess sustainability of effects.

Post Cycle Therapy (PCT):

As a non-hormonal peptide, Adipotide does not suppress the hypothalamic-pituitary-gonadal (HPG) axis like anabolic steroids. Therefore, traditional SERM-based PCT (e.g., with Clomid or Nolvadex) is not applicable. However, research into metabolic recovery is crucial. Supportive compounds like GHK-Cu for tissue repair or BPC-157 for systemic healing may be explored in experimental settings after an Adipotide research cycle. Monitoring basic metabolic panels is essential.

Liver & Kidney Support:

While not hepatotoxic like oral steroids, the apoptosis of fat cells releases stored metabolites, which the liver and kidneys must process. In research settings, incorporating support supplements is prudent. Atorvastatin (for lipid management research) and proper hydration are considered. GLOW is another Dragon Pharma product designed for detoxification support that may be relevant in comprehensive research models.

Storage Instructions

To maintain the stability and potency of the lyophilized peptide, Dragon Pharma Adipotide 10 mg must be stored in a specific manner:

• Unreconstituted (Powder): Store the sealed vial in a freezer at or below -20°C (-4°F). Under these conditions, the peptide remains stable for up to 24 months. Avoid repeated freeze-thaw cycles.
• After Reconstitution: Once reconstituted with bacteriostatic water, the solution should be stored refrigerated at 2°C to 8°C (36°F to 46°F) and used within a short timeframe as specified in research guidelines (often within 7-14 days). Never freeze the reconstituted solution.
• General: Keep the vial in its original packaging, protected from light and moisture. Ensure the storage environment is clean and secure.